Avita Medical Inc (Avita Medical) develops and distributes a portfolio of regenerative products, tissue-engineered products for the treatment of burns, scars, wounds and skin defects. Its lead product, RECELL system, is a regenerative product for the treatment of wounds caused by burns. RECELL is used mainly in conjunction with conventional treatments such as mesh grafting for burns and reconstructive procedures. RECELL offers advantages over conventional mesh grafting methods.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s research and development (R&D) focuses on developing new standard products to meet the diverse needs of its customers. The company aims to develop solutions for the potential treatment of a wide range of skin injuries or defects using the RECELL System. The company’s pipeline includes RECELL Go for the treatment of thermal burns (both partial and full thickness) and other full-thickness skin defects. The company invested US$20.8 million in R&D activities in FY2023, which increased 50% YoY.